| 摘要 |
FIELD: medicine, pharmacy. SUBSTANCE: invention relates to agents normalizing metabolism, compensating deficiency in Mg, Ca and Zn in body, arresting the development of inflammatory, psoriasis and osteoporosis symptoms due to transmembrane delivery of cations of bivalent metals and their incorporation to intracellular synthesis. The proposed agent represents a compound as linear or ladder dimmers, trimers or metallopolymers of acids in Krebs's cycle and/or amino acids, and/or their salts. Agent provides normalization of metabolic processes associated with such trace elements as Mg, Ca and Zn. EFFECT: valuable medicinal properties of agent, expanded assortment of agents. 4 cl, 1 dwg, 6 tbl, 11 ex |
